1Wiliams MS, Mayner RE, Daniel NJ, et al. New developments in the measurement of haemagglutinin content of influenza virus vaccines by singleradial-immunodiffusion.J Biol Stand, 1980,8:289-296.
2Gerdil C.The annual production cycle for influenza vaccine. Vaccine,2003,21 (16):1776-1779.
3Warburton MF. Desoxycholste-split influenza vaccine. Bull World Health Organ, 1969,41 (3) :639-641.
4Gross PA, Ennis FA, Gaerlan PF,et al. Comparison of new triton X-100 and tween-ether-treated split-treated vaccines in children. J Clin Microbiol, 1981,14(5) :534-538.
7Chen I. J, Tao F Y, Lu Q B. Advancs in rcscarh of Chinese' gi- ant salamander[J]. J Shanghai Fish Uni, 2003, 12:110 114.
8Geng Y, W,Vang K Y, Zhou Z Y, et al. First Report of a Ranair- us Associated with Morbidity and Morlalih in Farmed Chinese Giant Salamanders (Andrias davidianus)[J]. J Comp Pathol, 2010,145 : 95-102.
10Kamaraj G. , Lakshmi N M, Srinivasan V A. Validation of beta- propiolactone (BPL) as an inaetivant for infectious bovine rhino- tracheitis (IBR) virus[J]. Res Vet Sci, 2008, 85(3): 589- 594.
